Global News

Calling all clinical research personnel

Monday, October 23, 2017

The Pulse on Global Trials by Matthew Howes

In recent years, a global talent shortage has hampered strategic growth for many organizations. According to the ManPower Group, 36% of employers globally report talent shortages, the highest in seven years.

[Read More]

Phase III Lusutrombopag study shows positive efficacy

Friday, October 20, 2017

Shionogi & Co. announced it will present positive efficacy and safety results from a global phase III study (L-PLUS 2) of lusutrombopag (S-888711), an investigational, once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist, at the 2017 American Association for the Study of Liver Diseases (AASLD) Liver Meeting to be held October 20-24 in Washington, D.C.

[Read More]

AMRA, BioTelemetry partner on NASH/NAFLD clinical trials

Friday, October 20, 2017

AMRA, the international leader in body composition analysis, and BioTelemetry Research (BTR), a global imaging and cardiac core lab, announced the formation of an exclusive alliance for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) clinical trials. This first-to-market partnership will advance imaging science and benefit clinical trial sponsors in several musculoskeletal and metabolic therapeutic areas.

[Read More]

Accenture joins Partnership on AI

Friday, October 20, 2017

Accenture has joined the Partnership on AI, an alliance of businesses, researchers, academics and policy makers that work to advance the understanding of artificial intelligence (AI) technology and develop best practices on the challenges and opportunities within the field. Accenture joins other prominent industry leaders who share its commitment to advancing the field of AI so that it benefits people and society. Accenture will actively contribute its own insights, research and capabilities in areas including Responsible AI, and will dedicate people and resources to collaborate with Partnership on AI members to help address important global challenges such as food, diversity, inclusion, health, education and economic opportunity.

[Read More]

Institut Curie, Pierre Fabre Partner on immuno-oncology

Friday, October 20, 2017

Institut Curie and the IRPF (Institut de Recherche Pierre Fabre) will collaborate on new therapeutic strategies to advance cancer treatment for patients. The objective of this novel partnership is to dissect the biology of novel therapeutically tractable targets and evaluate the impact of innovative pharmacological approaches leveraging the Institut Curie’s biological models.

[Read More]

WuXi AppTec acquires ResearchPoint Global

Friday, October 20, 2017

WuXi AppTec, a global pharmaceutical, biotechnology and medical device open-access capability and technology platform, has acquired ResearchPoint Global (RPG), a U.S.-based CRO with expertise spanning across all major therapeutic areas. Upon the closing of this acquisition, RPG will become a wholly-owned subsidiary of WuXi, and will continue to focus on growing its core competences and providing better clinical development services. The acquisition underscores a strategic step forward to expand WuXi’s clinical research capabilities in the U.S. and around the world, further strengthening WuXi’s integrated R&D capability platform.

[Read More]

CRF Health adds Neil Conroy and Daniella Mulder to team

Wednesday, October 18, 2017

CRF Health, a global provider of patient-centered eSource technology and service solutions for the life sciences industry, has made two senior appointments to support the continuing growth of the global business. CRF Health will expand its operations team with the addition of Neil Conroy as VP of Business Transformation, and Daniella Mulder as VP of Client Relations. These positions will be central in expanding CRF Health’s client services in the high-paced eCOA market.

[Read More]

Clinipace Worldwide Co-founder & CEO Jeff Williams to resign as CEO

Wednesday, October 18, 2017

Jeff Williams, Co-founder, President and CEO of Clinipace Worldwide, a global full-service CRO that he founded 14 years ago, has elected to move into an expanded advisory role with the company’s Board of Directors. He will be handing over his responsibilities to Jason Monteleone, who will assume the role of Chief Executive Officer. Williams will remain a Director and will focus on strategic initiatives on behalf of the Board of Directors. 

[Read More]

The evolution of mobile technology use in clinical trials

Wednesday, October 18, 2017

William Osler, a founder of Johns Hopkins University, was a clinician ahead of his time. He was one of the first doctors to bring medical students out of the lecture hall and to the patient’s bedside — a revolutionary format change in its day. His 1892 book, The Principles and Practice of Medicine, was labeled as an “imaginative new curriculum” that prevailed for 50 years.1 Osler once said, “The good physician treats the disease; the great physician treats the patient who has the disease.”

[Read More]